Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000636

Director sold 81,435 shares at an average $17.08 ($1,390,611)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-06-26 Sale : show line 1 in the form −48,001 $16.83 $807,857 2,521,445 I
2017-06-27 Sale : show line 2 in the form −33,434 $17.43 $582,755 2,488,011 I
Open-market sales · 81,435 sh · avg $17.08 · $1,390,611
Loading xslF345X03/vonemster_form4jun262017.xml…